You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 24, 2025

Details for Patent: 10,961,195


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 10,961,195 protect, and when does it expire?

Patent 10,961,195 protects AKYNZEO and is included in one NDA.

This patent has eight patent family members in eight countries.

Summary for Patent: 10,961,195
Title:Crystalline forms of an NK-1 antagonist
Abstract: The present invention is related to crystalline forms of 2-(3,5-bis(trifluoromethyl)phenyl)-N,2-dimethyl-N-(6-(4-methylpiperazin-1- -yl)-4-(o-tolyl)pyridin-3-yl)propanamide which is an NK-1 antagonist useful in the treatment of induced vomiting and other disorders.
Inventor(s): Bacilieri; Christian (Breganzona, CH), Frasca; Gionata (Minusio, CH)
Assignee: Helsinn Healthcare SA (Pazzallo, CH)
Application Number:16/863,038
Patent Claim Types:
see list of patent claims
Compound;
Patent landscape, scope, and claims:

Analyzing the Scope and Claims of United States Patent 10,961,195: A Comprehensive Guide

Introduction

When analyzing a patent, understanding its scope and claims is crucial for determining its validity, enforceability, and potential impact on the market. This article will provide a detailed analysis of the scope and claims of United States Patent 10,961,195, using various tools and resources available from the United States Patent and Trademark Office (USPTO) and other intellectual property databases.

Understanding Patent Scope and Claims

Definition of Patent Scope

The scope of a patent refers to the breadth and depth of the protection granted by the patent. It is defined by the claims, which are the legally binding descriptions of the invention[4].

Importance of Claims

Claims are the heart of a patent, as they delineate what is protected by the patent. They must be clear, concise, and exact to meet statutory requirements[4].

Tools for Patent Analysis

Patent Public Search

The USPTO's Patent Public Search tool is a powerful resource for analyzing patents. It provides two modern interfaces that enhance access to prior art, allowing users to search and analyze patent documents more efficiently[1].

Global Dossier

The Global Dossier service offers access to the file histories of related applications from participating IP Offices. This can help in understanding the global patent family and related citations, classifications, and office actions[1].

Common Citation Document (CCD)

The CCD application consolidates citation data from multiple IP offices, providing a single point of access to prior art citations for a patent family. This is particularly useful for understanding the international patent landscape[1].

Analyzing Patent 10,961,195

Retrieving the Patent Document

To analyze the patent, start by retrieving the patent document using the USPTO's Patent Public Search tool or other patent databases like the Unified Patents Portal.

Reading the Claims

The claims section of the patent is where the legal boundaries of the invention are defined. Here, you will find the independent and dependent claims that outline what is protected.

Understanding Claim Types

  • Independent Claims: These claims stand alone and define the invention without reference to other claims.
  • Dependent Claims: These claims refer back to an independent claim and further limit the scope of the invention[3].

Analyzing Claim Language

The language used in the claims is critical. Look for clarity, specificity, and any potential ambiguities. The USPTO recommends using clear, concise, and exact terms to ensure the patent meets statutory requirements[4].

Examining Prior Art

Use tools like the Global Dossier and CCD to identify prior art cited by various IP offices. This helps in understanding how the patent office viewed the novelty and non-obviousness of the invention[1].

Patent Family and Citations

Review the patent family to see related applications and citations. This can provide insights into the evolution of the invention and its global protection status[1].

Statistical Analysis

Patent Claims Research Dataset

The USPTO's Patent Claims Research Dataset can provide statistical insights into patent claims. This dataset includes detailed information on claims from US patents and applications, which can help in analyzing the scope and complexity of the claims in Patent 10,961,195[3].

Claim-Level Statistics

Analyze claim-level statistics to understand the dependency relationships between claims and the overall scope of the patent. This can be done using the dataset files provided by the USPTO, such as the patent_claims_stats and pgpub_claims_stats files[3].

Legal and Policy Considerations

Patent Quality

Ensure that the patent meets the statutory requirements for novelty, non-obviousness, and clarity. The USPTO's Enhanced Patent Quality Initiative and GAO recommendations can provide guidelines on what constitutes a quality patent[4].

Office Actions and Examinations

Review any office actions and examiner comments to understand the examination process and any challenges faced during the patent application process. The Global Dossier can help in identifying office actions across different IP offices[1].

International Patent Landscape

Searching International Patent Offices

To understand the global protection of the invention, search databases from other international intellectual property offices such as the European Patent Office (EPO), Japan Patent Office (JPO), and World Intellectual Property Organization (WIPO)[1].

Machine Translations

Utilize machine translation services provided by these offices to access patent documents in different languages, which can be crucial for a comprehensive global analysis[1].

Practical Applications and Market Impact

Market Domination

Understanding the scope and claims of a patent can help businesses in strategizing market domination. By knowing what is protected, companies can avoid infringement and identify opportunities for innovation and differentiation.

Licensing and Litigation

Clear understanding of the patent's scope can also inform licensing agreements and litigation strategies. It helps in negotiating stronger licensing terms and defending against potential infringement claims.

Key Takeaways

  • Clear Claims: Ensure that the claims are clear, concise, and exact to meet statutory requirements.
  • Prior Art: Analyze prior art to understand the novelty and non-obviousness of the invention.
  • Global Protection: Review the global patent family and citations to understand the international protection status.
  • Statistical Analysis: Use datasets to analyze claim-level statistics and understand the scope and complexity of the patent.
  • Legal Considerations: Ensure the patent meets statutory requirements and review office actions and examiner comments.

FAQs

Q: How do I search for a specific patent using the USPTO's Patent Public Search tool?

A: You can search for a specific patent by entering the patent number in the search bar of the Patent Public Search tool.

Q: What is the importance of the Common Citation Document (CCD) in patent analysis?

A: The CCD consolidates citation data from multiple IP offices, providing a single point of access to prior art citations for a patent family.

Q: How can I determine the global protection status of a patent?

A: Use the Global Dossier service to access the file histories of related applications from participating IP Offices and review citations and classifications.

Q: What are the key elements of a quality patent?

A: A quality patent must meet statutory requirements for novelty, non-obviousness, and clarity, and be upheld if challenged in a lawsuit or other proceeding[4].

Q: How can statistical datasets help in analyzing patent claims?

A: Statistical datasets, such as the USPTO's Patent Claims Research Dataset, provide detailed information on claims and claim-level statistics, helping to understand the scope and complexity of the patent[3].

Sources

  1. USPTO - Search for patents: https://www.uspto.gov/patents/search
  2. ACUS - U.S. Patent Small Claims Court: https://www.acus.gov/research-projects/us-patent-small-claims-court
  3. USPTO - Patent Claims Research Dataset: https://www.uspto.gov/ip-policy/economic-research/research-datasets/patent-claims-research-dataset
  4. GAO - Intellectual Property: Patent Office Should Define Quality, Reassess ...: https://www.gao.gov/products/gao-16-490

More… ↓

⤷  Try for Free


Drugs Protected by US Patent 10,961,195

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Helsinn Hlthcare AKYNZEO netupitant; palonosetron hydrochloride CAPSULE;ORAL 205718-001 Oct 10, 2014 RX Yes Yes ⤷  Try for Free ⤷  Try for Free Y Y ⤷  Try for Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 10,961,195

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 2015323515 ⤷  Try for Free
Canada 2960599 ⤷  Try for Free
China 107001275 ⤷  Try for Free
European Patent Office 3197871 ⤷  Try for Free
Japan 2017529380 ⤷  Try for Free
South Korea 20170063768 ⤷  Try for Free
Taiwan 201613888 ⤷  Try for Free
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.